CDMO
Contract Development and Manufacturing Organization
Every pitch and position made on this ticker, across every competition and newsletter issue in the archive.
- Times pitched
- 2
- Long / short
- 2 / 0
- Avg. return
- —
- Verdicts
- Inconclusive 2
position
Spring 2023
MS
long
inconclusive
Newsletter
CDMO has improved its balance sheet through capital raises and is now investing in future growth. The company is expected to add significant capacity, which could lead to a valuation of only 10 times
position
Spring 2023
Laughing Water Capital
long
inconclusive
Newsletter
Avid Bioservices is a contract drug manufacturing organization that is expanding its manufacturing footprint. They are guiding to $150 million in revenue for fiscal '23 and could reach $400 million in